Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth .
Despite a significant net loss, Kestra Medical Technologies Ltd (KMTS) reports robust revenue growth and strategic advancements in sales territories and product innovation. Related Stocks: KMTS
Read the full articleYou might also wanna read
Kestra Medical Technologies (NASDAQ:KMTS) Revenue Beat and EPS Miss Create Mixed Setup After Recent Rally
Kestra Medical Technologies beat Q4 revenue estimates at $28.64M but missed EPS forecasts with a -$0.67 loss. The stock surged 20% in the la
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript
Revenue surged 66% in Q4 as prescriptions climbed 63% year over year.
Cintas (NASDAQ:CTAS) Q4 Earnings Deliver Quality Growth Amid EPS Beat and Record Margins
Cintas Q4 earnings beat EPS estimates with record 51% gross margin, while revenue slightly missed. Shares rose 0.9% pre-market on strong pro
Cohen & Steers NYSE:CNS Delivers Steady Q2 Results, Revenue Beats Slightly
Cohen & Steers Q2 2026 results: revenue of $152.73M beats estimates, EPS of $0.85 slightly misses. Stock rises 1.17% after-hours on steady p
Second Quarter Report 2026
SERSTECH GROUP, 1 APRIL - 30 JUNE 2026 Net sales amounted to KSEK 9 658 (4 563)EBITDA amounted to KSEK -2 426 (-9 041)EBIT amounted to KSEK
Abbott raises 2026 profit forecast on strength in diagnostics, heart devices
Abbott’s quarterly sales in its medical devices segment grew 9% to US$5.85 billion
Comments
Sign in to join the conversation.
No comments yet. Be the first.